New Zealand’s Douglas Pharmaceuticals has gained Food and Drug administration approval to sell its acne medication, isotretinoin, in the United States.

Abano Healthcare Group has today announced its interim results for the six months to 30 November 2011.

Pacific Edge, the biomedical firm specialising in cancer detection, posted a smaller first-half loss as it pushes on with bringing its Cxbladder product to market in the US.

Wakefield Health said adjusted first-half net profit rose nearly 33 percent, reflecting revenue growth from work for ACC and district health boards (DHBs) and good control of costs in a still relatively subdued market.

Dunedin-based biomedical company Pacific Edge has added to its intellectual property suite with a highly sought-after European patent awarded for its gastric cancer detection technology.

Pharmaceuticals and medical supplies distributor Ebos Group backed away from an acquisition in Britain because of deteriorating market conditions in Europe but is currently evaluating another “significant” Australasian purchase.

Wakefield Health Ltd. said first half sales rose about 5% and trading profit was up about 10% but it is unlikely to maintain these growth rates in the second half.

Wakefield Health Ltd., the hospital operator which recently took control of Norfolk Investment Ltd., said it's entered into a deal to buy an interest in Endoscopy Auckland Ltd. and Laparoscopy Auckland Ltd. as part of its ongoing expansion strategy.